Presentation is loading. Please wait.

Presentation is loading. Please wait.

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Published bySophia Snow Modified over 6 years ago

Similar presentations

Presentation on theme: "Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M"— Presentation transcript:

1 Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome 
Yuqian Cui, M.D., Ph.D., Yuhua Shi, M.D., Ph.D., Linlin Cui, M.D., Ph.D., Ting Han, M.D., Xuan Gao, M.D., Zi-Jiang Chen, M.D., Ph.D.  Fertility and Sterility  Volume 102, Issue 1, Pages e2 (July 2014) DOI: /j.fertnstert Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Distribution of serum antimüllerian hormone (AMH) concentration in women with and without polycystic ovary syndrome (PCOS). Fertility and Sterility  , e2DOI: ( /j.fertnstert ) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

3 Figure 2 Relationship between serum antimüllerian hormone (AMH) levels and antral follicle count (AFC), FSH, body mass index (BMI), and LH in infertile control subjects and patients with polycystic ovary syndrome (PCOS). Fertility and Sterility  , e2DOI: ( /j.fertnstert ) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

4 Supplemental Figure 1 Flow chart. AMH = antimüllerian hormone; PCOS = polycystic ovary syndrome. Fertility and Sterility  , e2DOI: ( /j.fertnstert ) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

Download ppt "Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M"

Similar presentations

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the.

Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the.
Direct vitamin D3 actions on rhesus macaque follicles in three-dimensional culture: assessment of follicle survival, growth, steroid, and antimüllerian.

Direct vitamin D3 actions on rhesus macaque follicles in three-dimensional culture: assessment of follicle survival, growth, steroid, and antimüllerian.
Efficacy of predictive models for polycystic ovary syndrome using serum levels of two antimüllerian hormone isoforms (proAMH and AMHN,C)  Michael W. Pankhurst,

Efficacy of predictive models for polycystic ovary syndrome using serum levels of two antimüllerian hormone isoforms (proAMH and AMHN,C)  Michael W. Pankhurst,
Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,
Variation in circulating antimüllerian hormone precursor during the periovulatory and acute postovulatory phases of the human ovarian cycle  Michael W.

Variation in circulating antimüllerian hormone precursor during the periovulatory and acute postovulatory phases of the human ovarian cycle  Michael W.
Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries  Robert L. Rosenfield, M.D., Kristen Wroblewski,

Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries  Robert L. Rosenfield, M.D., Kristen Wroblewski,
Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study  Thi.

Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study  Thi.
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis  Anuja Dokras, M.D., Ph.D., Shari.

Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis  Anuja Dokras, M.D., Ph.D., Shari.
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis  Héctor F. Escobar-Morreale, M.D., Ph.D., Manuel Luque-Ramírez,

Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis  Héctor F. Escobar-Morreale, M.D., Ph.D., Manuel Luque-Ramírez,
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Infertility evaluation and treatment among women in the United States

Infertility evaluation and treatment among women in the United States
Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women  Babak Mokhlesi, M.D.,

Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women  Babak Mokhlesi, M.D.,
Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc

Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc
Patient-tailored ovarian stimulation for in vitro fertilization

Patient-tailored ovarian stimulation for in vitro fertilization
Antimüllerian hormone levels decrease in women using combined contraception independently of administration route  Sanna Kallio, M.D., Johanna Puurunen,

Antimüllerian hormone levels decrease in women using combined contraception independently of administration route  Sanna Kallio, M.D., Johanna Puurunen,
Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,
Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study  Cem Celik, M.D., Nicel.

Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study  Cem Celik, M.D., Nicel.
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 

Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 

Similar presentations

Ads by Google